These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 6142464)

  • 1. Beta-blockers in the secondary prevention of myocardial infarction: a review of clinical trials of 12 months or more duration.
    Decorde P
    Pharmatherapeutica; 1984; 3(8):515-25. PubMed ID: 6142464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxprenolol in myocardial infarction survivors: brief review of the European Infarction Study results in the light of other beta-blocker post infarction trials.
    Schröder R
    Z Kardiol; 1985; 74 Suppl 6():165-72. PubMed ID: 2869616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-blocker underuse in secondary prevention of myocardial infarction.
    Everly MJ; Heaton PC; Cluxton RJ
    Ann Pharmacother; 2004 Feb; 38(2):286-93. PubMed ID: 14742768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Beta-Blocker Pooling Project (BBPP): subgroup findings from randomized trials in post infarction patients. The Beta-Blocker Pooling Project Research Group.
    Eur Heart J; 1988 Jan; 9(1):8-16. PubMed ID: 2894312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating the effect on patient outcomes of appropriate and inappropriate use of beta-blockers as secondary prevention after myocardial infarction in a medicaid population.
    Fernandes AW; Madhavan SS; Amonkar MM
    Clin Ther; 2005 May; 27(5):630-45. PubMed ID: 15978313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Beta blockers or ACE inhibitors following myocardial infarction in patients with diabetes?].
    Gystad K; Carlsen SM
    Tidsskr Nor Laegeforen; 2000 Sep; 120(21):2565-9. PubMed ID: 11070998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-adrenergic blockade for survivors of acute myocardial infarction.
    Frishman WH; Furberg CD; Friedewald WT
    N Engl J Med; 1984 Mar; 310(13):830-7. PubMed ID: 6142420
    [No Abstract]   [Full Text] [Related]  

  • 8. A multicenter study on timolol in secondary prevention after myocardial infarction.
    Acta Med Scand Suppl; 1983; 674():1-129. PubMed ID: 6580807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-blockade after myocardial infarction: practical implications of major clinical trials.
    Rehnqvist N; Olsson G
    J Cardiovasc Pharmacol; 1987; 10 Suppl 2():S10-4. PubMed ID: 2481157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does beta-blocker therapy improve clinical outcomes of acute myocardial infarction after successful primary angioplasty?
    Kernis SJ; Harjai KJ; Stone GW; Grines LL; Boura JA; O'Neill WW; Grines CL
    J Am Coll Cardiol; 2004 May; 43(10):1773-9. PubMed ID: 15145098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Six-year follow-up of the Norwegian Multicenter Study on Timolol after Acute Myocardial Infarction.
    Pedersen TR
    N Engl J Med; 1985 Oct; 313(17):1055-8. PubMed ID: 2864634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Beta-blocker Heart Attack Trial.
    Furberg CD
    Z Kardiol; 1985; 74 Suppl 6():159-63. PubMed ID: 2869615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary and secondary prevention of myocardial infarction and strokes: an update of randomly allocated, controlled trials.
    Yusuf S; Lessem J; Jha P; Lonn E
    J Hypertens Suppl; 1993 Jun; 11(4):S61-73. PubMed ID: 8104243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Timolol Myocardial Infarction Study: an evaluation of selected variables.
    Rodda BE
    Circulation; 1983 Jun; 67(6 Pt 2):I101-6. PubMed ID: 6342836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-blocker compliance, mortality, and reinfarction: validation of clinical trial association using insurer claims data.
    Kleiner SA; Vogt WB; Gladowski P; DeVries A; Levin G; Antonucci C; Fong J
    Am J Med Qual; 2009; 24(6):512-9. PubMed ID: 19890140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutic value of the long-term administration of beta-adrenergic blockaders after myocardial infarct].
    Tomov I
    Vutr Boles; 1984; 23(3):16-25. PubMed ID: 6147044
    [No Abstract]   [Full Text] [Related]  

  • 17. [Improved prognosis using beta blockers after myocardial infarct?].
    Weisswange A
    Lebensversicher Med; 1984 Jan; 36(1):14-9. PubMed ID: 6141479
    [No Abstract]   [Full Text] [Related]  

  • 18. A review of ongoing trials of beta blockers in the secondary prevention of coronary heart disease.
    Cutler JA
    Circulation; 1983 Jun; 67(6 Pt 2):I62-5. PubMed ID: 6133645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of beta blockers in high-risk patients after myocardial infarction in conjunction with captopril and/or valsartan (from the VALsartan In Acute Myocardial Infarction [VALIANT] trial).
    Califf RM; Lokhnygina Y; Velazquez EJ; McMurray JJ; Leimberger JD; Lewis EF; Diaz R; Murin J; Pfeffer MA
    Am J Cardiol; 2009 Jul; 104(2):151-7. PubMed ID: 19576338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A long-term prevention study with oxprenolol in coronary heart disease.
    Taylor SH; Silke B; Ebbutt A; Sutton GC; Prout BJ; Burley DM
    N Engl J Med; 1982 Nov; 307(21):1293-301. PubMed ID: 6752712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.